Chia Tai TianQing Pharmaceutical Group
Lianyungang, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A major integrated Chinese pharma company developing innovative small molecule drugs for oncology and metabolic disorders.
OncologyMetabolic Diseases
Technology Platform
Integrated small molecule drug discovery and development platform, with expanding capabilities in biologics.
Opportunities
Significant growth opportunity from China's expanding healthcare coverage and aging population driving demand for its core therapeutic products.
Risk Factors
Heavy reliance on the domestic market exposes it to Chinese pricing and reimbursement policy volatility.
Competitive Landscape
Faces intense competition from both large domestic pharma giants and multinational corporations in the crowded Chinese oncology and metabolic markets.